BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23258953)

  • 1. CC-chemokine CCL15 expression and possible implications for the pathogenesis of IgE-related severe asthma.
    Shimizu Y; Dobashi K
    Mediators Inflamm; 2012; 2012():475253. PubMed ID: 23258953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.
    Yamamoto T; Kawada K; Itatani Y; Inamoto S; Okamura R; Iwamoto M; Miyamoto E; Chen-Yoshikawa TF; Hirai H; Hasegawa S; Date H; Taketo MM; Sakai Y
    Clin Cancer Res; 2017 Feb; 23(3):833-844. PubMed ID: 27492974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.
    Liu LZ; Zhang Z; Zheng BH; Shi Y; Duan M; Ma LJ; Wang ZC; Dong LQ; Dong PP; Shi JY; Zhang S; Ding ZB; Ke AW; Cao Y; Zhang XM; Xi R; Zhou J; Fan J; Wang XY; Gao Q
    Hepatology; 2019 Jan; 69(1):143-159. PubMed ID: 30070719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulation of CCL15 by human airway smooth muscle cells.
    Joubert P; Lajoie-Kadoch S; Wellemans V; Létuvé S; Tulic MK; Halayko AJ; Hamid Q
    Clin Exp Allergy; 2012 Jan; 42(1):85-94. PubMed ID: 22092970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
    D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
    D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.
    Escher SE; Forssmann U; Frimpong-Boateng A; Adermann K; Vakili J; Sticht H; Detheux M
    J Pept Res; 2004 Jan; 63(1):36-47. PubMed ID: 14984572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgE: lessons learned from effects on airway inflammation and asthma exacerbation.
    Fahy JV
    J Allergy Clin Immunol; 2006 Jun; 117(6):1230-2. PubMed ID: 16750979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis.
    Inamoto S; Itatani Y; Yamamoto T; Minamiguchi S; Hirai H; Iwamoto M; Hasegawa S; Taketo MM; Sakai Y; Kawada K
    Clin Cancer Res; 2016 Jan; 22(2):492-501. PubMed ID: 26341919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.
    Gao Y; Zhou Z; Lu S; Huang X; Zhang C; Jiang R; Yao A; Sun B; Wang X
    Stem Cells; 2016 Apr; 34(4):1112-22. PubMed ID: 26763650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cell‑derived CCL15 mediates the transmigration of fibrocytes through the CCL15‑CCR1 axis in vitro.
    Pang N; Lin Z; Wang X; Xu L; Xu X; Huang R; Li X; Li X; Li J
    Mol Med Rep; 2020 Dec; 22(6):5339-5347. PubMed ID: 33174007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab for asthma in adults and children.
    Normansell R; Walker S; Milan SJ; Walters EH; Nair P
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil-derived chemokine (hCCL15/23, mCCL6) interacts with CCR1 to promote eosinophilic airway inflammation.
    Du X; Li F; Zhang C; Li N; Huang H; Shao Z; Zhang M; Zhan X; He Y; Ju Z; Li W; Chen Z; Ying S; Shen H
    Signal Transduct Target Ther; 2021 Feb; 6(1):91. PubMed ID: 33640900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo.
    Hwang J; Kim CW; Son KN; Han KY; Lee KH; Kleinman HK; Ko J; Na DS; Kwon BS; Gho YS; Kim J
    FEBS Lett; 2004 Jul; 570(1-3):47-51. PubMed ID: 15251437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments.
    Pelaia G; Vatrella A; Busceti MT; Gallelli L; Terracciano R; Maselli R
    Curr Drug Targets; 2015; 16(2):171-8. PubMed ID: 25523898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab in children.
    Licari A; Marseglia A; Caimmi S; Castagnoli R; Foiadelli T; Barberi S; Marseglia GL
    Paediatr Drugs; 2014 Dec; 16(6):491-502. PubMed ID: 25404353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-immunoglobulin E, a monoclonal antibody to treat respiratory disorders].
    Cabrera-Navarro P
    Arch Bronconeumol; 2006 May; 42(5):241-5. PubMed ID: 16740240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.